Concepedia

Publication | Closed Access

Inflammatory response and treatment tolerance of long‐term infusion of the anti‐GD<sub>2</sub> antibody ch14.18/CHO in combination with interleukin‐2 in patients with high‐risk neuroblastoma

16

Citations

15

References

2018

Year

Abstract

LTI of ch14.18/CHO combined with s.c.IL-2 shows an improved tolerance in subsequent cycles allowing outpatient treatment.

References

YearCitations

Page 1